Introduction {#sec1-1}
============

Matrix metalloproteinases (MMPs), collectively known as matrixins, make up a multigene family of 23 zinc-dependent endopeptidases that mediate degradation of virtually all extracellular matrix (ECM) molecules, including native and denatured collagen.[@ref1] They are commonly divided into collagenases, gelatinases, stromelysin, matrilysins, membrane-type MMPs, and others. The biological activities of MMPs can be regulated post-transcriptionally or by interaction with specific MMP tissue inhibitors (TIMPs).[@ref4] The balance between activated MMPs and their inhibitors determines the extent of ECM remodelling.[@ref3] MMPs play different roles in the oral environment,[@ref3] where their activity has been documented in various stages of tissue development and in pathological processes such as periodontal disease, caries, and dental pulp inflammation.^[@ref1],[@ref5]^ In particular, mounting evidence indicates that the MMPs found in the dentin matrix or in saliva could be responsible for the dentin organic matrix degradation that follows bacterial acid-induced demineralisation, suggesting an important role for them in caries control and/or progression.^[@ref5],[@ref13]^ Although several MMPs, as far as other important molecules, have been identified in healthy and pathological human dentin and pulp, including caries and inflammation,^[@ref4],[@ref9],[@ref18]^ data regarding their presence and activity in oral tissues are few, and their precise action remains to be elucidated.

MMP-13 is a collagenase 3 and can degrade ECM components as well as a variety of substrates such as collagen, gelatin, aggrecan, perlecan and fibronectin.[@ref4] Collagenase expression has been documented in dental pulp and in odontoblasts,^[@ref4],[@ref22]^ in particular a recent work has detected the expression of MMP-13 in pulp of sound and caries teeth, suggesting an important role for it in pulp turnover.[@ref4] This and a more recent study,[@ref28] reporting that genetic variations in MMP-13 may contribute to interindividual differences in caries susceptibility, suggested to us that different MMP-13 expression profiles might be found in the two conditions and led us to investigate, for the first time, the immunohistochemical expression of MMP-13 in the dentin of sound and decayed teeth.

Materials and Methods {#sec1-2}
=====================

Specimen collection {#sec2-1}
-------------------

We studied 12 permanent premolars (2 sound and 10 decayed) that had been extracted at the School of Dentistry, University of Catania (Italy) in view of orthodontic treatment or because of advanced or gross caries, respectively. Sample collection was approved by the local Research Ethics Committee and the informed written consent of each patient was obtained. Exclusion criteria for caries specimens adopted were prior endodontic therapy, any associated dental condition, periapical pathology suggesting the presence of necrotic pulp. Only fully erupted teeth were included and all extractions, which were performed under local anaesthesia (2% lidocaine 1:80,000 epinephrine), were uncomplicated. Immediately after extraction teeth were placed in saline and fixed in 10% buffered formalin.

Non-caries specimens selected were teeth displaying no colour change indicating caries in the dentin; those with advanced or gross caries were teeth where the colour change extended through more than half of the dentin thickness.

Hard dental tissue preparation for immunohistochemistry {#sec2-2}
-------------------------------------------------------

A groove perpendicular to the long tooth axis was cut with a dental burr equipped with an air/water spray system. Specimens were cut horizontally into halves at the cemento-enamel junction and fixed in 10% neutral buffered formalin. They were demineralised in ethylenediaminetetraacetic acid (EDTA) decalcification fluid (41.3 g disodium EDTA, 4.4 g NaOH in 1000 mL distilled water) for 6 weeks at 4°C. After an overnight wash, each half was dehydrated in graded ethanols and processed for embedding in paraffin wax with the anatomical orientation preserved. Sections 3-4 μm in thickness were cut according to routine procedures, mounted on silane-coated slides, and finally air-dried.

Immunohistochemistry {#sec2-3}
--------------------

Samples were processed as previously described.[@ref29] Endogenous peroxidase activity was quenched with 3% H~2~O~2~ for 10 min. Nonspecific antibody binding was blocked by treatment with normal horse/goat serum diluted 1:20 in phosphate buffered saline (PBS) and 0.1% bovine serum albumin. Sections were placed in a microwave oven (750 W) (5 min × 3) in capped polypropylene slide-holders with citrate buffer (pH 6.0), to unmask antigen sites. They were subsequently incubated with mouse monoclonal anti-MMP-13 (anti-collagenase 3) antibody (NeoMarkers, Lab Vision, Fremont, CA, USA) diluted 5-10 μl/mL in PBS overnight at 4°C. The secondary antibody, biotinylated anti-mouse/anti-rabbit IgG, was applied for 30 min, followed by avidin--biotin-- peroxidase complex (Vector Elite Kit Abbott, Chicago, IL, USA) for 30 min, all at room temperature. The immunoreaction was visualised by incubating sections for 4 min in 0.1 % 3,3-diaminobenzidine and 0.02% hydrogen peroxide solution (DAB Substrate kit, Vector Laboratories, Burlingame, CA, USA). Sections were then lightly counterstained with Mayer's haematoxylin (Histolab Products AB, Göteborg, Sweden) and finally mounted in GVA (glycerol vinyl alcohol aqueous mounting solution) (Zymed, San Francisco, CA, USA).

Positive and negative controls {#sec2-4}
------------------------------

Positive controls consisted of breast carcinoma sections; negative controls were tooth sections treated with normal rabbit serum instead of the specific antibodies.

Evaluation of immunohistochemical results {#sec2-5}
-----------------------------------------

The staining status was identified as either negative or positive; positive staining was defined as the presence of brown chromogen. MMP-13 staining intensity and the proportion of immunopositive cells were examined independently by three anatomists by light microscopy and recorded. Intensity of staining (IS) was graded independently by three anatomists on a 0 to 4 scale according to the following semiquantitative assessment: 0=no detectable staining, 1, weak staining; 2, moderate staining; 3, strong staining; 4, very strong staining. The proportion of MMP-13-immunopositive cells (extent score=ES) was also evaluated independently by three anatomists and scored as a percentage of the final number of 100 cells into 4 categories: -, ≤5 %; +, 6--30 %; ++, 31--50 %; +++, ≥50%, and ++++ = ≥75%. Counting was performed at 200x magnification. The final staining score (FSS) was the sum of IS and ES.

Statistical analysis {#sec2-6}
--------------------

Data were analysed using the Mann-Whitney U-test. Significance was set at P\<0.05. Mean and standard deviation were calculated for the FSS. Interobserver agreement was expressed as kappa coefficient. All data were analysed with the SPSS program (SPSS® release 16.0, Chicago, IL, USA).

Results {#sec1-3}
=======

MMP-13 immunostaining was detected in dentin of both sound and caries teeth with different immunoexpression patterns. Sound dentin exhibited very weak immunoreactivity that was detected only at the peritubular level (ES +; IS: 1) ([Figure 1](#fig001){ref-type="fig"}). On the contrary dilated dentinal tubuli close to the caries process showed very strong immunoreactivity (ES ++++; IS: 4) both in the peritubular zone and in Tomes' processes (plasma membrane and central area) ([Figure 2A-B](#fig002){ref-type="fig"} and [3A-B](#fig003){ref-type="fig"}). MMP-13 immunostaining diminished with increasing distance from the caries process ([Figure 2C](#fig002){ref-type="fig"}). Immunoreactivity was not detected in the sections incubated with non-immune serum. The kappa coefficient was 0.89 (almost perfect agreement). The mean FSS was 3.97±0.52 (range: 3.7-5.8).

Discussion {#sec1-4}
==========

This study shows MMP-13 upregulation in dentin of human caries teeth. In particular, its immunoexpression was weak and confined to the peritubular area in sound dentin and strong at the peritubular level and in Tomes' processes in caries dentin, where it decreased as the distance from the decay process increased.

MMP-13 was first detected in breast cancer and subsequently discovered in a variety of other pathological tissues such as malignant squamous epithelium, chondrosarcoma, and melanoma.^[@ref30],[@ref31]^ MMP-13 expression has been documented in fibroblasts of healing gingival wounds, in temporomandibular joint disc with internal derangement and in developing and remodelled tissues including osteoblasts.[@ref32] In contrast, its expression in normal adult tissue is low or absent.^[@ref30],[@ref31]^ Although collagenase expression has already been described in dental pulp and in odontoblasts, its role in odontoblasts has not been considered important.^[@ref4],[@ref22],[@ref26]^ In our opinion the conspicuous MMP-13 immunoexpression found in caries dentin in our study suggests that it could be crucially involved in promoting caries progression due to its ability to degrade many ECM compo-nents.[@ref4] The contribution of MMP-13 to caries lesion progression might thus be related not only to its direct ECM degrading activity but also to its involvement in the activation of other MMPs.[@ref31]

The MMP-13 immunoexpression pattern found in our study, with greater expression being found close to caries lesions, is similar to the one described for other MMPs (*e.g*., MMP-20, 2, 8, and 9) in crown and root lesions,^[@ref15],[@ref19],[@ref27]^ despite often diverse expression levels.[@ref27] Interestingly, the different immunolabelling of caries and sound teeth documented in our study mimics the expression pattern of TIMP-1 found in human caries dentin in a previous study by our group.[@ref37] TIMP-1 seems to play a role in curbing hard dental tissue breakdown in the post-injury pathological processes taking place in human dental tissues (*e.g*., caries lesions),[@ref11] even though the level of TIMPs found in active caries lesions is insufficient to block the progression of dental hard tissue destruction mediated by MMPs, among other agents.[@ref36] Nonetheless, an important role of MMPs in progression and maintenance of the caries process is proved by several recent studies of the effect of synthetic MMP inhibitors, such as doxycycline and chlorhexidine, in reducing collagen degradation in demineralised dentin.[@ref38]

In conclusion, our findings suggest a role for MMP-13 in caries. Further research is warranted to elucidate the role of MMPs in dentin-pulp complex organisation, pulp pathology, and caries pathogenesis and evolution. Since MMP inhibitors have been shown to slow down the progression of dental caries their utilisation in caries prevention should be further investigated.

![Very weak MMP-13 immunoreaction in sound dentin in the peritubular area. Scale bar: 100 µm.](ejh-2014-1-2318-g001){#fig001}

![A) Transverse section of a caries tooth with dilated dentinal tubuli displaying very strong MMP-13 immunoreaction in the peritubular area and in Tomes' processes (black arrow); B) Longitudinal section of a caries tooth with dilated dentinal tubuli exhibiting very strong MMP-13 immunoreaction in Tomes' processes (plasma membrane and central area ) (black arrow). C) Transverse section of a caries tooth with very strong MMP-13 immunostaining in the peritubular area (black arrow) that decrease with the increasing distance (asterisk) from the caries lesion. Scale bars: 100 µm.](ejh-2014-1-2318-g002){#fig002}

![Higher magnifications of the previous figures. A) Transverse section of caries tooth with a very strong MMP-13 immunoreaction in the peritubular area and in Tomes' processes. B) Longitudinal section of caries tooth with a very strong MMP-13 immunoreaction in the peritubular area and in Tomes' processes. C) Transverse section of caries tooth with a very strong MMP-13 immunoreaction in the peritubular area and decreasing immunopositivity with the increasing distance from the caries lesion. Scale bars: 10 µm.](ejh-2014-1-2318-g003){#fig003}
